Evidence map›Paper›PMID 36211963›Full record

ArticleFrontiers in cellular and infection microbiology2022

Non-thermal plasma causes

Petra Kašparová, Eva Vaňková, Martina Paldrychová, Alžběta Svobodová, Romana Hadravová, Irena Jarošová Kolouchová, Jan Masák, Vladimir Scholtz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Breaking the barrier: disruption of bacterial biofilms using microwave radiation.Frontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Enzyme Production and Inhibitory Potential ofAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Serratiopeptidase Affects the Physiology ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Petra KašparováLaboratory of Applied Biology, Department of Biotechnology, University of Chemistry and Technology in Prague, Prague, Czechia.
Eva VaňkováLaboratory of Applied Biology, Department of Biotechnology, University of Chemistry and Technology in Prague, Prague, Czechia.
Martina PaldrychováLaboratory of Applied Biology, Department of Biotechnology, University of Chemistry and Technology in Prague, Prague, Czechia.
Alžběta SvobodováLaboratory of Applied Biology, Department of Biotechnology, University of Chemistry and Technology in Prague, Prague, Czechia.
Romana HadravováViral and Microbial Proteins, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czechia.
Irena Jarošová KolouchováLaboratory of Applied Biology, Department of Biotechnology, University of Chemistry and Technology in Prague, Prague, Czechia.
Jan MasákLaboratory of Applied Biology, Department of Biotechnology, University of Chemistry and Technology in Prague, Prague, Czechia.
Vladimir ScholtzLaboratory of Non-thermal Plasma, Department of Physics and Measurements, University of Chemistry and Technology in Prague, Prague, Czechia.
University of Chemistry and Technology, Prague · CZCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing risk of antibiotic failure in the treatment of

Indexed as

Plasma GasesPseudomonas InfectionsAnti-Bacterial AgentsBiofilmsEndopeptidasesGelatinasesHemolysin ProteinsHumansPancreatic ElastasePeptide HydrolasesPlanktonPseudomonas aeruginosaPyocyanineQuorum SensingVirulence FactorsAnti-Bacterial AgentsEndopeptidasesGelatinasesHemolysin ProteinsPancreatic ElastasePeptide HydrolasesPlasma GasesPyocyanineVirulence Factorsantivirulence factorsbiofilm disruptioncold atmospheric plasma (CAP)combined therapyhaemolytic activity

Identifiers

PMID36211963
PMCPMC9544392
OpenAlexW4297009330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.